Advancing Cell Therapies Together: ACTRIS at the 29th APBMT Congress

We had the privilege of participating in the 29th Annual Congress of the Asia-Pacific Bone Marrow Transplantation Group, where the theme, Harnessing the Immune System, fostered valuable discussions on cutting-edge treatments and innovations shaping the future of patient care.

At our booth, we were delighted to share how ACTRIS was established as a national facility to centralise resources, manpower, and capabilities across Singapore to enhance operational efficiencies. This approach also aims to scale up the manufacturing of cell and gene therapy products, potentially moderating the cost of these treatments and expanding patient access in time to come.

The congress offered an invaluable opportunity to engage with like-minded professionals and thought leaders in the CGT space, all united by a shared commitment to advancing breakthrough therapies and improving patient outcomes.

A heartfelt thank you to everyone who visited our booth to learn more about ACTRIS and our initiatives in the clinical translation of advanced cell therapies. Together, we are shaping the future of healthcare and making meaningful strides toward better patient outcomes!

You may view our LinkedIn post here.